COMMUNIQUÉS West-GlobeNewswire

International study offers new path to reduce spinal taps in young infants with fevers
08/12/2025
New evidence from a six-country study led by the Montreal Children’s Hospital and Children’s National Hospital shows simple blood and urine tests could spare many young infants with fevers from more invasive procedures [...]
Nelipak® Acquires Merrill’s Packaging
08/12/2025
Strengthens presence in growing healthcare manufacturing and innovation hubs. CRANSTON, R.I., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Nelipak ® Corporation (“Nelipak”), a leading global provider of healthcare packaging [...]
Surgery Partners and Baylor Scott & White Health Form Joint Venture to Expand Access to Quality Care
08/12/2025
The Physicians Centre Hospital in Bryan to become a Baylor Scott & White facility, as health system grows to keep up with population increase in the Brazos Valley BRENTWOOD, Tenn., and BRYAN/COLLEGE STATION, Texas, [...]
Ipsen - Novembre 2025 - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
08/12/2025
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social (conformément à l’article L.233-8 II du Code de commerce et à l’article 223-16 du Règlement Général de l’ [...]
Ipsen - November 2025 - Monthly information relative to the total number of voting rights and shares composing the share capital
08/12/2025
Monthly information relative to the total number of voting rights and shares composing the share capital (in accordance with Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Regulation [...]
Zelluna ASA - Mandatory notification of trade
08/12/2025
Reference is made to the private placement (the " Private Placement ") and the retail offering through PrimaryBid announced by Zelluna ASA on 3 November 2025. Please see the attached PDMR-form related to share lending [...]
Geron Corporation Presents New Data at ASH 2025 Highlighting the Relationship Between Treatment-Emergent Cytopenias and Clinical Benefit of RYTELO® (Imetelstat) in Lower-Risk MDS
08/12/2025
Oral presentation from pooled analyses of the IMerge population suggests that treatment-emergent cytopenias may reflect on-target effects associated with meaningful clinical outcomes, including hemoglobin increases and [...]
Hemp Hop Expands with New Cannabis Dispensary in Houston
08/12/2025
HOUSTON, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Hemp Hop has officially opened its new cannabis dispensary in Houston at 1103 Bomar Street Suite 200 . This marks an important step in the company’s growth as it expands beyond [...]
Moleculin Announces New Annamycin Collaboration in Brain Tumors
08/12/2025
Investigator-Initiated Preclinical studies at CIC biomaGUNE aimed at combatting Glioblastoma Multiforme Research will evaluate effects of intra-arterial delivery of Annamycin HOUSTON, Dec. 08, 2025 (GLOBE NEWSWIRE) -- [...]
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
08/12/2025
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS 8 December 2025 at 15.30 EET Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion [...]
NetraAI Study Accepted for Publication in npj Digital Medicine, Part of the Nature Portfolio
08/12/2025
TORONTO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier artificial intelligence (AI) company that is transforming clinical [...]
Coherus Announces Six-Year JUPITER-02 Follow-up Results Showing LOQTORZI® plus Chemotherapy Nearly Doubles Median Overall Survival in Nasopharyngeal Carcinoma
08/12/2025
-6 Years Long-term survival data reinforce potential benefit to patient survival in treating recurrent or metastatic nasopharyngeal carcinoma with LOQTORZI in combination with chemotherapy - REDWOOD CITY, Calif., Dec. [...]
Menarini Group Presents Elacestrant (ORSERDU®) Phase 2 Combination Data in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2025 San Antonio Breast Cancer Symposium
08/12/2025
In addition, the expansive elacestrant clinical development program updates reinforce its potential as a backbone endocrine therapy in combination settings, as well as in both metastatic and early stage breast cancer. [...]
CytoDyn to Showcase PD-L1 Upregulation and Improved Survival in Metastatic Triple Negative Breast Cancer at the San Antonio Breast Cancer Symposium
08/12/2025
Leronlimab treatment is associated with upregulation of PD-L1 in circulating tumor cells and cancer-associated macrophage-like cells Remarkably longer survival was observed in patients treated with leronlimab in [...]
SS Innovations Submits 510(k) Premarket Notification to the FDA for the Company’s SSi Mantra Surgical Robotic System
08/12/2025
-- Submission covers multiple indications including general, urological, colorectal, gynecological and cardiac surgeries -- FORT LAUDERDALE, Fla., Dec. 08, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. ( [...]
IRADIMED Announces Special Cash Dividend of $0.50 Per Share
08/12/2025
ORLANDO, Fla., Dec. 08, 2025 (GLOBE NEWSWIRE) -- iRadimed Corporation (the “Company”) (NASDAQ: IRMD), announced that its Board of Directors (the “Board”) approved a special cash dividend of $0.50 per share of the [...]
rYojbaba Subsidiary Sakai Seikotsuin Serves as an Official Trainer at the 2025 Taipei Wake Open
08/12/2025
FUKUOKA, Japan, Dec. 08, 2025 (GLOBE NEWSWIRE) -- rYojbaba Co., Ltd. (Nasdaq: RYOJ) ("rYojbaba" or the "Company"), a Japanese labor consulting and health services company, announced that its health services subsidiary, [...]
Ernexa Therapeutics Presents New Preclinical Data at American Society of Hematology (ASH) Annual Meeting on Lead Cell Therapy Candidate for Treatment of Ovarian Cancer
08/12/2025
Positive results of ERNA-101 in ovarian cancer models demonstrated promising survival benefit and immune activation, underscoring the potential for broad oncology applications, including hematologic malignancies [...]
Polyrizon Completes FDA Pre-Submission Meeting for PL-14 Allergy Blocker Nasal Spray
08/12/2025
Ra’anana, Israel, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a biotechnology company focusing on the development of intranasal products, today announces that it has [...]

Pages